Services More Info Insurance Doctors About
Call to Schedule

Comprehensive care for inflammatory bowel diseases (IBD)

We look forward to providing you with professional inflammatory bowel disease treatment in Dallas and Lubbock in a friendly and welcoming environment. We are a member of Baylor Scott & White Health. We work closely with Baylor Scott & White North Texas Colon and Rectal Associates to bring you comprehensive IBD care.

Read More

Something went wrong.

There are no locations with the configured parameters:

Insurances accepted

Baylor Scott & White has established agreements with several types of insurance to ensure your health needs are covered.

Insurance listings are subject to change without prior notice. Please call the hospital or health plan to verify coverage information before scheduling your visit/procedure.
By searching you agree to these terms
  • Aetna - (23)
    Aetna Signature Administrators
    Select
    Choice POS II
    Health Network Option
    Aetna Medicare Eagle II (PPO)
    Aetna Medicare Choice Plan (PPO)
    Aetna Medicare Choice II Plan (PPO)
    Group Retiree Medicare PPO - Limited to Exxon/Mobil
    QPOS
    Open Access Select
    Open Access Managed Choice
    Aetna Medicare Freedom Preferred Plan (PPO)
    Aetna Medicare Prime Plan (HMO)
    Aetna Medicare Freedom Plan (PPO)
    Aetna Medicare Dual Complete Plan (HMO D-SNP)
    Health Network Only
    HMO
    Managed Choice
    Open Access Elect Choice
    Aetna Medicare Eagle Plan (PPO)
    Open Choice PPO
    Aetna Medicare Value Plan (HMO)
    STAR
  • American Health Advantage of Texas - (1)
    American Health Advantage of Texas HMO I-SNP
  • Baylor Scott & White Health Plan - (2)
    BSW Extended PPO
    BSW Premier HMO-Group
  • Blue Cross Blue Shield - (22)
    Federal FEP Blue Focus
    Federal Standard Option
    Blue Choice
    Blue Essentials
    High Performance Network
    Blue Cross Group Medicare Advantage (PPO)
    TRS-Care Standard
    TRS-ActiveCare Primary HD
    TRS-ActiveCare Primary
    TRS-ActiveCare 2
    ParPlan
    Blue Advantage - Silver
    Blue Advantage - Gold
    Blue Advantage - Bronze
    TRS-ActiveCare Primary+
    HealthSelect
    Blue Cross Medicare Advantage (HMO)
    Blue Advantage Plus - Silver
    Consumer Directed HealthSelect
    Federal Basic Option
    Blue Premier
    Blue Premier Access
  • Cigna - (9)
    Open Access Plus
    Open Access Plus In-Network
    Point of Service Open Access
    Cigna HealthSpring
    Open Access
    Choice Fund
    LocalPlus
    Cigna Medicare Advantage
    LocalPlus In-Network
  • DFW ConnectedCare - (1)
    American Airlines Employee Benefit Plan
  • EHN - (1)
    Employers Health Network
  • First Health/Coventry - (1)
    First Health/Coventry Network
  • FirstCare Health Plans - (1)
    CHIP
  • HealthSmart - (2)
    Preferred Network
    Accel Network
  • Humana - (9)
    Humana Preferred
    ChoiceCare
    Humana Gold Plus SNP-DE (HMO D-SNP)
    HumanaChoice (Regional PPO)
    HumanaChoice (PPO)
    Humana USAA Honor with Rx (PPO)
    Humana Honor (PPO)
    Humana Gold Choice (PFFS)
    National POS
  • Imagine Health - (1)
    Imagine Health Network
  • Nebraska Furniture Mart - (1)
    Pearl
  • Parkland Community Health Plan - (2)
    CHIP
    STAR - HealthFirst
  • PHCS Network - (1)
    PHCS Primary PPO
  • Superior Health Plan - (6)
    Wellcare
    Wellcare by Allwell
    STAR+PLUS
    Ambetter Core EPO - Silver
    Ambetter Core EPO - Bronze
    Ambetter Core EPO - Gold
  • Superior HealthPlan - (1)
    STAR+PLUS
  • TriWest HealthCare - (1)
    Community Care Network
  • United HealthCare - (23)
    All Savers
    Charter
    Charter Balanced
    Charter Plus
    Choice Plus
    Core
    Choice
    Navigate Balanced
    Navigate
    Core Essential
    EDGE
    Navigate Plus
    Nexus ACO - Open Access
    Nexus ACO - Referral Required
    Options
    Select Plus
    UnitedHealthcare Group Medicare Advantage (PPO)
    AARP Medicare Advantage Choice (PPO)
    AARP Medicare Advantage SecureHorizons Plan 2 (HMO-POS)
    AARP Medicare Advantage Walgreens (PPO)
    UnitedHealthcare Medicare Advantage Choice (Regional PPO)
    Select
    AARP Medicare Advantage SecureHorizons Plan 1 (HMO-POS)
We’re sorry!

We couldn’t find any results for ""

Terms
Close

Insurance listings are subject to change without prior notice. Please call your physician's office or your health or insurance plan to verify coverage information prior to scheduling your visit or procedure. Not all members participating in contracted networks have "in network" access. In network participation may change from time to time without prior notice. Independent providers (which could include, for example only, anesthesiologists, radiologists, pathologists, emergency medicine physicians, advance practice professionals, and other independent providers of healthcare services) may deliver part of your care, and such providers may be considered out-of-network on your health and insurance plans even if the Facility may be considered in network. If you desire additional information as to the providers who may be involved in providing your care, you can either ask your treating provider (who may know some of the specialists or groups who could be involved) or you can request a list of Facility-based physician groups by calling the following toll free number: 1.877.810.0372. This list is updated annually and is subject to change without prior notice.


Your rights and protections against surprise medical bills

Medical services

​​​​​​​​​​​​​

Baylor Scott & White Center for Inflammatory Bowel Diseases offers expertise and IBD treatment options conveniently located near you.

  • Crohn's disease

    Crohn's disease

    Crohn's disease is an inflammatory bowel disease (IBD) in which chronic inflammation causes damage to the gastrointestinal tract, typically the small intestine and/or the colon. There is no medical or surgical cure for Crohn's disease at the present time.

    Learn more about Crohn's disease
  • Digestive diseases

    Digestive diseases

    We specialize in the diagnosis and treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

    We perform a variety of procedures to diagnosis and monitor the digestive tract:

    • Capsule study
    • Chromoendoscopy
    • Colonoscopy
    • Enteroscopy
    • Ileoscopy
    • Pouchoscopy
    • Sigmoidoscopy
    • Upper endoscopy (EGD)

    In addition, we offer infusion therapies to manage symptoms:

  • Ulcerative colitis

    Ulcerative colitis

    Ulcerative colitis is an inflammatory bowel disease (IBD) in which inflammation causes damage to the large intestine—the colon and rectum. It is a chronic disease without medical cure at the present time.

    Learn more about ulcerative colitis

Crohn's disease

Crohn's disease is an inflammatory bowel disease (IBD) in which chronic inflammation causes damage to the gastrointestinal tract, typically the small intestine and/or the colon. There is no medical or surgical cure for Crohn's disease at the present time.

Learn more about Crohn's disease

Digestive diseases

We specialize in the diagnosis and treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

We perform a variety of procedures to diagnosis and monitor the digestive tract:

  • Capsule study
  • Chromoendoscopy
  • Colonoscopy
  • Enteroscopy
  • Ileoscopy
  • Pouchoscopy
  • Sigmoidoscopy
  • Upper endoscopy (EGD)

In addition, we offer infusion therapies to manage symptoms:

Ulcerative colitis

Ulcerative colitis is an inflammatory bowel disease (IBD) in which inflammation causes damage to the large intestine—the colon and rectum. It is a chronic disease without medical cure at the present time.

Learn more about ulcerative colitis

Pay bill

Baylor Scott & White Health is pleased to offer you multiple options to pay your bill. View our guide to understand your Baylor Scott & White billing statement.

We offer two online payment options:

Other payment options:

  • Pay by mail

    To ensure that your payment is correctly applied to your account, detach the slip from your Baylor Scott & White billing statement and return the slip with your payment. If paying by check or money order, include your account number on the check or money order.

    Please mail the payment to the address listed on your statement.

  • Pay by phone

    Payments to HTPN can be made over the phone with our automated phone payment system 24 hours a day, seven days a week. All payments made via the automated phone payment system will post the next business day. Please call 1.866.377.1650.

    If you need to speak to someone about a bill from a Baylor Scott & White Hospital, our Customer Service department is available to take payments over the phone from Monday through Friday from 8:00 AM - 5:00 PM and can be reached at 1.800.994.0371.

  • Pay in person

    Payments can be made in person at the facility where you received services.

Financial assistance

At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a team member before, during or after care is received.

View financial assistance options

qr-code.svg
Mobile makes it easy
Just like we make it easy to get care when your child is sick or injured, our top-rated app, MyBSWHealth, can simplify keeping them healthy. The app lets you book appointments, message your pediatrician, view your child’s medical records and schedule virtual same-day care from your computer, smartphone or tablet.
myBSWHealth app displayed on a phone
Text BETTER to 88408
  • Google Play icon
  • App Store icon

Patient forms

To ensure that your visit to our office is as convenient and efficient as possible, we are pleased to offer our registration forms online. The patient registration form may be completed electronically and printed for better legibility or completed manually.

Patient education and resources

​​​​​​​​​​​​​

Procedure prep

Where to go for procedures

GI/Endoscopy Lab
Truett Hospital, First Floor
Baylor University Medical Center Campus

3501 Junius St
Dallas, TX 75246

News and media

Crohn's Disease Life Expectancy
Dr. Dassopoulos was recently interviewed by US News and World Report on the topic of mortality of Crohn's disease. Dr. Dassopoulos emphasized that the life span of individuals suffering from Crohn's disease is essentially the same as that of the general population.
Read article

IBS and IBD: More Than Just Tummy Trouble
Listen to Dr. Dassopoulos on KERA, Vital Signs series, explain the differences between IBS and IBD.
Read article

Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part  1)
Dr Dassopoulos discusses the differences between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
Watch the video

Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 2)
Dr. Dassopoulos educates on the most common symptoms, causes and therapies of IBD.
Watch the video

Medication cost assistance

Pharmaceutical companies offer patient assistance programs which provide assistance to those who need financial support in paying for their medication. Please note, these programs usually apply to those who are uninsured. To find information on various patient assistance programs providing assistance for specific medication, the links are:

Educational resources

BSWH patient education

Online resources

Research and clinical trials

​​​​​​​​​​​​​

Baylor Scott & White Center for Inflammatory Bowel Diseases conducts a number of ongoing research studies that may benefit you, including clinical trials of medications that hold the promise of improving the health of patients with ulcerative colitis or Crohn's disease. To learn more, contact the Dallas clinical trials office at 214.818.9688.

Research overview

The Center for IBD Research performs cutting-edge, impactful translational and basic research on IBD to improve our understanding of the disease and develop better treatments.

  • Inflammatory bowel diseases and autophagy
  • Crohn’s disease of the ileum
  • Barrier function of the intestinal epithelium
  • Colitis-associated colorectal cancer
  • Intestinal stem cell responses to inflammation and diet

Dr. Theiss published an article on factors driving inflammation progression to cancer.

Faculty

  • Arianne L. Theiss, PhD, Research Director
  • Themistocles Dassopoulos, MD, Medical Director
  • Jie Han, MD, MS

Crohn's disease trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease

A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn’s Disease who have failed anti-TNF therapy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease.

A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Ulcerative colitis trials

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis (UC)

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis